2 years ago
BHC
AnalystsDavid SteinbergDavid Steinberg's Stock Forecasts
AnalystsDavid Steinberg
Analyst Ranking
Top 20%
#980 out of 4875 analysts
Average Return
+17.19%
Win Rate
50%10 out of 20
Risk vs Reward
Poor
Good
David Steinberg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocular Therapeutix IncOCUL | +305.00% | $5.00 | $20.25 | 2020-03-17 - 2021-03-17 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +182.15% | $33.67 | $95.00 | 2020-04-28 - 2021-04-28 | Strong Buy |
Bausch Health Companies IncBHC | +81.68% | $16.32 | $29.65 | 2020-04-23 - 2021-04-23 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +60.29% | $14.00 | $22.44 | 2017-11-07 - 2018-11-07 | Strong Buy |
Jazz Pharmaceuticals PLCJAZZ | +53.87% | $105.77 | $162.75 | 2020-04-06 - 2021-04-06 | Strong Buy |
David Steinberg Analyst Color
Get additional color on David Steinberg's coverage of popular stocks
2 years ago
BHC
4 years ago
PRGO
David Steinberg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bausch Health Companies IncBHC | 7 | Hold | $8.00 | +74.29% | Downgrades | 3 months ago |
Perrigo Co PLCPRGO | 1 | Strong Buy | $63.00 | N/A | Upgrades | 4 years ago |
Supernus Pharmaceuticals IncSUPN | 3 | Strong Buy | $40.00 | N/A | Upgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Strong Buy | $120.00 | N/A | Maintains | 4 years ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $188.00 | N/A | Maintains | 5 years ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Scpharmaceuticals IncSCPH | 2 | Strong Buy | $12.00 | N/A | Maintains | 7 years ago |
Optinose IncOPTN | 1 | Strong Buy | $405.00 | N/A | Initiates Coverage On | 8 years ago |
Savara IncSVRA | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.